Ovarian Cancer Treatment Advancements: Insights from MOASC Spotlight 2025 Ovarian 3 Mins Read At the MOASC Spotlight 2025, Dr. Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S., Medical Director of the Gynecologic Cancer Program at City…
Module #1: Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer Prostate Cancer Treatment 1 Min Read This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…
